Execution, Finance, Operations and Pharmaceuticals

Diverse Boards Are More Innovative

The Horizons Tracker

NOVEMBER 29, 2023

According to a study conducted by the Indiana University Kelley School of Business, diversity in terms of gender, race, and ethnicity has proven to be beneficial for companies operating in the United States. “We looked at their experiences and not just their demographic background—the more functional aspect of diversity.

Diversity

Diversity Innovation Biotechnology Short-term

6 Proven Tactics to Design an Effective Executive Healthcare Resume

Strategy Driven

APRIL 3, 2014

Crafting and writing a branded healthcare executive resume, that differs from the traditional medical resume, can make a significant difference in your executive job search results and improve the opportunities to land that next-level position in pharmaceutical, biotech and medical device industries.

Tactics

Tactics Execution Pharmaceuticals Human Capital

Introducing 100 Coaches: Pay It Forward Champions

Marshall Goldsmith

FEBRUARY 8, 2018

Teaches leadership to executives and emerging leaders around the world. a holding company that operates seven distinct business. Former Chairman and Chief Executive Officer Global Debt Registry (MHR). Corporate Executives. Former Executive VP and Head of Strategy & Transformation at TMB Bank.

Executive Coaching

Executive Coaching CEO Magazine Banking

Performance Measurement

Strategy Driven

JULY 13, 2011

Value: The Four Cornerstones of Corporate Finance by Tim Koller. While you can find numerous books focused on the topic of corporate finance, few offer the type of information managers need to help them make important decisions day in and day out. Discusses the four foundational principles of corporate finance.

ROIC

ROIC Balanced Scorecard Metrics McKinsey

The Questions Executives Should Ask About 3D Printing

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Executive teams need to assess their industries’ and companies’ time horizons for the technology, because they will have a huge amount of strategic and business process planning to do before their companies adopt it.

Supply Chain

Supply Chain Execution Analysis Technology

Research: Business School Really Does Influence How Students Make Decisions Later On

Harvard Business Review

AUGUST 8, 2018

From various archival sources, including the Marquis Who’s Who and Bloomberg’s Executive Profile & Biography, we gathered information on their educational background, such as the school they attended for an MBA and their year of graduation. To test our argument, we collected data on 2,031 CEOs who ran 640 large U.S.

Influence

Influence Education Pharmaceuticals Finance

The Rise of the COO

Harvard Business Review

NOVEMBER 9, 2011

The answers may not be as self-evident as many executives think. Of the 97 largest listed companies in the UK and the Eurozone in 2010, only 37 had a COO in their executive ranks. Most COOs in Europe are seasoned executives; they were 48 years old, on average, when they were appointed. What do you think?

COO

COO Sample Telecommunications Automotive

The Internet of Things Will Change Your Company, Not Just Your Products

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. Operations. It also took into account their roles in changing patient behavior.

Productivity

Productivity Products Company Engineering

Corporate Learning Programs Need to Consider Context, Not Just Skills

Harvard Business Review

NOVEMBER 10, 2017

Despite the amount they invest in corporate learning, organizations continue to struggle to connect these programs with the day-to-day work of strategy execution. ” But to enable strategy execution, learning departments need to reorient from what they’re trying to teach to where these things show up in the work.

Skills

Skills Agility Learning-by-Doing Content

80% of Companies Don’t Know If Their Products Contain Conflict Minerals

Harvard Business Review

JANUARY 4, 2017

There are similar stories in the electronics industry, pet food, pharmaceuticals, and even national security. This regulation came as a result of concerns that the exploitation and trade of conflict minerals by armed groups was helping to finance conflict in the DRC region and contributing to its emergency humanitarian crisis.

Supply Chain

Supply Chain Productivity Products Company

What a Changing NAFTA Could Mean for Doing Business in Mexico

Harvard Business Review

JUNE 20, 2017

Multinational companies operating in Mexico are facing a great deal of uncertainty. Firms in innovation-driven industries, such as pharmaceuticals and medical devices, have long supported greater standardization across borders, with stronger intellectual property protections and enforcement of regulatory standards.

Supply Chain

Supply Chain Depreciation Uncertainty Marketing

What’s Driving Superstar Companies, Industries, and Cities

Harvard Business Review

OCTOBER 25, 2018

The superstars tend to be more involved in global flows of trade and finance, more digitally mature, and they dominate the lists of the most valued companies, the most valued brands, the most desirable places to work, and the most innovative companies. The link between superstar firms, sectors, and cities is complex.

Industry

Industry Company GDP Bottom-up

How Merck Is Trying to Keep Disrupters at Bay

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care

Health Care Venture Capitalist Strategic Fit Pharmaceuticals

The “Maximize Profits” Trap in Decision Making

Harvard Business Review

SEPTEMBER 19, 2016

Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. It is a simple, clear, and highly useful criterion — for routine decisions in businesses operating in competitive markets and with sound legal systems. How should you make this decision?

ROI

ROI Long-term Conflict of Interest Pharmaceuticals

What to Know About Doing Business in Iran

Harvard Business Review

MAY 5, 2016

Senior executives should not lose perspective on the enormous opportunities in Iran, but they must be prepared to navigate some serious challenges. sanctions are delaying these projects being financed. Senior executives should be ready to trace the origins of and combat grey market trade and counterfeits of their products in Iran.

Tourism

Tourism Banking Due Diligence Hotels

Leadership Digital

Diverse Boards Are More Innovative

6 Proven Tactics to Design an Effective Executive Healthcare Resume

Trending Sources

Introducing 100 Coaches: Pay It Forward Champions

Performance Measurement

The Questions Executives Should Ask About 3D Printing

Research: Business School Really Does Influence How Students Make Decisions Later On

The Rise of the COO

The Internet of Things Will Change Your Company, Not Just Your Products

Corporate Learning Programs Need to Consider Context, Not Just Skills

80% of Companies Don’t Know If Their Products Contain Conflict Minerals

What a Changing NAFTA Could Mean for Doing Business in Mexico

What’s Driving Superstar Companies, Industries, and Cities

How Merck Is Trying to Keep Disrupters at Bay

The “Maximize Profits” Trap in Decision Making

What to Know About Doing Business in Iran

Stay Connected